Literature DB >> 17889832

Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA.

Zhongxing Liang1, Hui Wu, Santosh Reddy, Aizhi Zhu, Sijia Wang, Dean Blevins, Younghyoun Yoon, Yawei Zhang, Hyunsuk Shim.   

Abstract

miRNAs have been shown to function as regulatory molecules and to play an important role in cancer progression. Very little is currently known about the increasing invasion and metastasis of breast cancer due to the loss of expressive levels of certain miRNAs in breast tumor cells. In order to determine whether the CXCR4/SDF-1 pathway is regulated by expression of miRNAs, we designed and synthesized pre-miRNA against CXCR4. This double-stranded miRNA gene was ligated with a miR-155-based Block-iT Pol II miR RNAi Expression Vector (Invitrogen). Expression levels of CXCR4 in CXCR4-miRNA-transfected breast tumor cells had significantly declined. These cells exhibited reduced migration and invasion in vitro. Furthermore, they formed fewer lung metastases in vivo compared to ctrl-miRNA-transfected cells. These data support the conclusion that miRNA against CXCR4 can serve as an alterative means of therapy to lower CXCR4 expression and to block the invasion and metastasis of breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889832     DOI: 10.1016/j.bbrc.2007.09.007

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  55 in total

1.  Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer.

Authors:  Dan Guo; Jiayi Huang; Jianping Gong
Journal:  Mol Cell Biochem       Date:  2011-12-14       Impact factor: 3.396

Review 2.  Emerging role of microRNAs in drug-resistant breast cancer.

Authors:  Sarmila Majumder; Samson T Jacob
Journal:  Gene Expr       Date:  2011

3.  HDAC3 selectively represses CREB3-mediated transcription and migration of metastatic breast cancer cells.

Authors:  Han-Cheon Kim; Kyung-Chul Choi; Hyo-Kyoung Choi; Hee-Bum Kang; Mi-Jeong Kim; Yoo-Hyun Lee; Ok-Hee Lee; Jeongmin Lee; Young Jun Kim; Woojin Jun; Jae-Wook Jeong; Ho-Geun Yoon
Journal:  Cell Mol Life Sci       Date:  2010-05-15       Impact factor: 9.261

Review 4.  MicroRNAs in skin and wound healing.

Authors:  Jaideep Banerjee; Yuk Cheung Chan; Chandan K Sen
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

Review 5.  Advances in microRNAs: implications for gene therapists.

Authors:  Rebecca T Marquez; Anton P McCaffrey
Journal:  Hum Gene Ther       Date:  2008-01       Impact factor: 5.695

6.  Protective role of LRRC3B in preventing breast cancer metastasis and recurrence post-bupivacaine.

Authors:  Gong-Sheng Li; Gao-Yin Kong; Yi Zou
Journal:  Oncol Lett       Date:  2017-08-18       Impact factor: 2.967

7.  CXCR4-Targeted Nanocarriers for Triple Negative Breast Cancers.

Authors:  Asish C Misra; Kathryn E Luker; Hakan Durmaz; Gary D Luker; Joerg Lahann
Journal:  Biomacromolecules       Date:  2015-07-22       Impact factor: 6.988

Review 8.  Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell.

Authors:  Georgia Sotiropoulou; Georgios Pampalakis; Evi Lianidou; Zissimos Mourelatos
Journal:  RNA       Date:  2009-06-26       Impact factor: 4.942

9.  The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12.

Authors:  Lorena Hernandez; Tatiana Smirnova; Dmitriy Kedrin; Jeffrey Wyckoff; Liyin Zhu; E Richard Stanley; Dianne Cox; William J Muller; Jeffrey W Pollard; Nico Van Rooijen; Jeffrey E Segall
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

10.  Overexpression of thioredoxin-1 reduces oxidative stress in the placenta of transgenic mice and promotes fetal growth via glucose metabolism.

Authors:  Takashi Umekawa; Takashi Sugiyama; Tomohisa Kihira; Nao Murabayashi; Lingyun Zhang; Kenji Nagao; Yuki Kamimoto; Ning Ma; Junji Yodoi; Norimasa Sagawa
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.